iuphar-db, grac and the iuphar/bps guide to pharmacology


Post on 23-Aug-2014




4 download

Embed Size (px)




  • www.guidetopharmacology.org IUPHAR-DB, GRAC and the IUPHAR/BPS Guide to PHARMACOLOGY Adam J. Pawson Monday 14th July 2014, WCP2014
  • The history of IUPHAR-DB The IUPHAR database of receptors and channels has been under development since 2000; Developed by a team of curators, guided by NC- IUPHAR and its international network of expert contributors; In-depth coverage of the properties and pharmacology of G protein-coupled receptors, voltage- and ligand- gated ion channels, and nuclear hormone receptors.
  • The history of IUPHAR-DB (2) Peer-reviewed by NC-IUPHAR subcommittees; data include: Gene and protein information IUPHAR nomenclature and synonyms Agonist , antagonist and allosteric modulator affinities Transduction mechanisms;Tissue distribution Functional assays; Physiological Functions Mouse gene knockout phenotypes Clinically-Relevant Mutations and Pathophysiology Gene expression changes in pathophysiology; Biologically significant variants Extensively referenced and linked to primary literature in PubMed Extensively linked to corresponding entries in other resources Provides unambiguous ligand structural information and peptide sequences
  • A new initiative In early 2011 a collaboration was initiated between IUPHAR and the British Pharmacological Society; To develop a single entry point to pharmacological information on drug targets and their ligands.
  • The IUPHAR/BPS Guide to PHARMACOLOGY A single entry point to pharmacological information originally contained in IUPHAR- DB and the 5th (2012) Edition of GRAC;
  • Introducing GRAC The Guide to Receptors and Channels (GRAC); Published since 2004; biennially by the British Journal of Pharmacology; Authoritative, but user-friendly publication, which allows a rapid overview of the key properties of a wide range of established or potential pharmacological targets; Provides information succinctly, so that a newcomer to a particular target group can identify the main elements at a glance.
  • Introducing GRAC (2) Concise target family summaries of the key properties of over 2000 established or potential drug targets G protein-coupled receptors Ligand-gated ion channels Other ion channels Nuclear hormone receptors Catalytic receptors Enzymes Transporters Overview summaries and comments on data Selective ligands and probes (radioligands and PET ligands where available) Further reading lists
  • Constructing the IUPHAR/BPS Guide to PHARMACOLOGY
  • Database content (Targets)
  • Database content (Ligands)
  • The IUPHAR/BPS Guide to PHARMACOLOGY A single entry point to pharmacological information originally contained in IUPHAR-DB and the 5th (2012) Edition of GRAC; Information presented in two levels of detail; concise and detailed views; Customised tables for selected targets.
  • Target pages
  • Target pages (2)
  • Target pages (3)
  • Target pages 4
  • Target pages 5
  • Target pages 6
  • Target pages 7
  • Target pages 8
  • Peptides
  • Peptides
  • Antibodies
  • Antibodies
  • Antibodies
  • Kinases All the human protein kinases and selected lipid kinases, including genomic and structural information for all the kinases; Additional information is provided on the 20 clinically-used kinase inhibitors [including summaries of clinical use and absorption, distribution, metabolism, and excretion (ADME) data]; Selected bioactivity data for approved kinase inhibitors; Data from published screening assays by DiscoveRx, EMD Millipore and Reaction Biology are also included for 71, 158 and 176 kinase inhibitors respectively; DiscoveRx data include links to theirTREEspot compound profile visualisation tool.
  • Kinases lestaurtinibImatinib
  • Proteases and hydrolases The database includes pages with genomic and structural information for 175 proteases and 14 hydrolases with activity records in ChEMBL; Detailed ligand activity (Ki or IC50) mapping has been curated for 46 proteases and 14 hydrolases for either approved prodrugs, drugs, clinical candidates or selected research compounds; MEROPS classification system adopted.
  • Proteases and hydrolases
  • Epigenetics We provide annotation on 127 epigenetics targets (chromatin modifying enzymes and bromodomain-containing proteins), along with activity data for 41 inhibitors.
  • Drugs andTargets in Alzheimers disease Database search functionality enables retrieval of implicated ligands and targets by disease name; A search for Alzheimers disease returns database entries for 43 ligands and 13 targets.
  • Live demos Booth # 70 Booth # 87-89
  • Acknowledgements Tony Harmar Michael Spedding, Steve Alexander, Ian McGrath and members of NC-IUPHAR NC-IUPHAR subcommittee chairs and members GRAC/Concise Guide contributors Joanna Sharman, Helen Benson, Elena Faccenda, Christopher Southan and Jamie Davies All past database curators


View more >